Canada markets close in 2 hours 26 minutes

AIM ImmunoTech Inc. (AIM)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
1.90000.0000 (0.00%)
As of 1:33PM EDT. Market open.
Currency in USD

Valuation Measures

Market Cap (intraday) 592.35M
Enterprise Value 352.09M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)544.98
Price/Book (mrq)1.42
Enterprise Value/Revenue 3400.68
Enterprise Value/EBITDA 7-3.30

Trading Information

Stock Price History

Beta (5Y Monthly) -0.82
52-Week Change 3-16.30%
S&P500 52-Week Change 330.48%
52 Week High 33.0600
52 Week Low 31.6500
50-Day Moving Average 31.9818
200-Day Moving Average 32.0680

Share Statistics

Avg Vol (3 month) 3416.32k
Avg Vol (10 day) 3191.3k
Shares Outstanding 547.85M
Implied Shares Outstanding 6N/A
Float 847.28M
% Held by Insiders 11.19%
% Held by Institutions 114.99%
Shares Short (Sep. 29, 2021) 41.07M
Short Ratio (Sep. 29, 2021) 42.59
Short % of Float (Sep. 29, 2021) 42.27%
Short % of Shares Outstanding (Sep. 29, 2021) 42.24%
Shares Short (prior month Aug. 30, 2021) 4937.89k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun. 10, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:44
Last Split Date 3Jun. 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-12,056.92%

Management Effectiveness

Return on Assets (ttm)-16.77%
Return on Equity (ttm)-29.67%

Income Statement

Revenue (ttm)130k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-42.50%
Gross Profit (ttm)-643k
EBITDA -14.94M
Net Income Avi to Common (ttm)-16.7M
Diluted EPS (ttm)-0.4550
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)41.14M
Total Cash Per Share (mrq)0.86
Total Debt (mrq)157k
Total Debt/Equity (mrq)0.24
Current Ratio (mrq)47.17
Book Value Per Share (mrq)1.36

Cash Flow Statement

Operating Cash Flow (ttm)-10.61M
Levered Free Cash Flow (ttm)-7.81M